Enhabit(US:EHAB) ZACKS·2026-03-04 23:55Core Viewpoint - Enhabit (EHAB) reported quarterly earnings of $0.14 per share, matching the Zacks Consensus Estimate, and showing a significant increase from $0.04 per share a year ago, indicating a positive earnings surprise of +3.70% [1] Financial Performance - Enhabit achieved revenues of $270.4 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.40%, and up from $258.2 million in the same quarter last year [2] - The company has exceeded consensus EPS estimates in all four of the last quarters [2] Stock Performance - Enhabit shares have increased approximately 47.5% since the beginning of the year, contrasting with a 0.4% decline in the S&P 500 [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.12 on revenues of $264.97 million, and for the current fiscal year, it is $0.56 on revenues of $1.09 billion [7] - The trend of estimate revisions for Enhabit was favorable prior to the earnings release, suggesting potential for continued positive performance [6] Industry Context - The Medical Services industry, to which Enhabit belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]